Literature DB >> 8007758

Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis.

R W Fuller1.   

Abstract

The physiological role of the serotonin transporter on serotonin neuronal membranes apparently is to inactivate serotonin that has been released into the synaptic cleft. Drugs that inhibit the uptake of serotonin increase the amount of serotonin in the synaptic cleft and enhance serotonergic neurotransmission. As an adaptive response to the increased amount of serotonin in the synaptic cleft, serotonin neurons decrease their firing and release of serotonin to limit the magnitude of the increase in extracellular serotonin concentration. The increase in extracellular serotonin in rat brain caused by inhibitors of the serotonin uptake carrier has been characterized by brain microdialysis coupled to liquid chromatography with electrochemical detection. These drugs cause rapid accumulation of extracellular serotonin in several brain regions, although the increase in frontal cortex may be smaller than in other nerve terminal regions or in the cell body-containing raphe region.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8007758     DOI: 10.1016/0024-3205(94)00876-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  50 in total

1.  Serotonin as a putative scavenger of hypohalous acid in the brain.

Authors:  Mike Kalogiannis; E James Delikatny; Thomas M Jeitner
Journal:  Biochim Biophys Acta       Date:  2015-12-14

Review 2.  Premature ejaculation: definition and drug treatment.

Authors:  Marcel D Waldinger
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Colocalization and regulated physical association of presynaptic serotonin transporters with A₃ adenosine receptors.

Authors:  Chong-Bin Zhu; Kathryn M Lindler; Nicholas G Campbell; James S Sutcliffe; William A Hewlett; Randy D Blakely
Journal:  Mol Pharmacol       Date:  2011-06-24       Impact factor: 4.436

4.  Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats.

Authors:  Rui Tao; Ibrahim M Shokry; John J Callanan; H Daniel Adams; Zhiyuan Ma
Journal:  Psychopharmacology (Berl)       Date:  2014-10-11       Impact factor: 4.530

5.  Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex.

Authors:  Tracy M Felton; Tommy B Kang; Stephan Hjorth; Sidney B Auerbach
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-04       Impact factor: 3.000

6.  Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat.

Authors:  Marian Geldof; Jan Freijer; Ludy van Beijsterveldt; Meindert Danhof
Journal:  Pharm Res       Date:  2007-08-21       Impact factor: 4.200

7.  Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine.

Authors:  E Le Poul; N Laaris; E Doucet; A M Laporte; M Hamon; L Lanfumey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

8.  Differential effects of acute and repeated citalopram in mouse models of anxiety and depression.

Authors:  Cedric Mombereau; Tamar L Gur; Jennifer Onksen; Julie A Blendy
Journal:  Int J Neuropsychopharmacol       Date:  2009-12-14       Impact factor: 5.176

9.  A microdialysis study of glycinamide, glycine and other amino acid neurotransmitters in rat frontal cortex and hippocampus after the administration of milacemide, a glycine pro-drug.

Authors:  M H Doheny; S Nagaki; P N Patsalos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

10.  Effects of 5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus on the antidepressant-like action of tramadol in the unpredictable chronic mild stress in mice.

Authors:  Ipek Yalcin; Stéphanie Coubard; Sylvie Bodard; Sylvie Chalon; Catherine Belzung
Journal:  Psychopharmacology (Berl)       Date:  2008-06-26       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.